Myotonic dystrophy types 1 and 2

Handbook of Clinical Neurology

Volumn 101, Issue , 2011, Pages 193-237

  Ashizawa, Tetsuo ^a   Sarkar, Partha S ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BOOK; HUMAN; MYOTONIA; MYOTONIC DYSTROPHY;

HUMANS; MYOTONIC DISORDERS; MYOTONIC DYSTROPHY;

EID: 79954591424     PISSN: 00729752     EISSN: None     Source Type: Book Series    
DOI: 10.1016/B978-0-08-045031-5.00015-3     Document Type: Book

References (365)

1. Abbruzzese C., Costanzi Porrini S., Mariani B., et al. Instability of a premutation allele in homozygous patients with myotonic dystrophy type 1. Ann Neurol 2002, 52:435-441.
2. Aldehag A.S., Jonsson H., Ansved T. Effects of a hand training programme in five patients with myotonic dystrophy type 1. Occup Ther Int 2005, 12:14-27.
3. Alwazzan M., Newman E., Hamshere M.G., et al. Myotonic dystrophy is associated with a reduced level of RNA from the DMWD allele adjacent to the expanded repeat. Hum Mol Genet 1999, 8:1491-1497.
4. Amack J.D., Mahadevan M.S. The myotonic dystrophy expanded CUG repeat tract is necessary but not sufficient to disrupt C2C12 myoblast differentiation. Hum Mol Genet 2001, 10:1879-1887.
5. Amack J.D., Mahadevan M.S. Myogenic defects in myotonic dystrophy. Dev Biol 2004, 265:294-301.
6. Amack J.D., Reagan S.R., Mahadevan M.S. Mutant DMPK 3'-UTR transcripts disrupt C2C12 myogenic differentiation by compromising MyoD. J Cell Biol 2002, 159:419-429.
7. American College of Medical Genetics/American Society of Human Genetics Huntington Disease Genetic Testing Working Group ACMG/ASHG statement. Laboratory guidelines for Huntington disease genetic testing. Am J Hum Genet 1998, 62:1243-1247.
8. Amorosi B., Giustini S., Rossi A., et al. Myotonic dystrophy (Steinert disease): a morphologic and biochemical hair study. Int J Dermatol 1999, 38:434-438.
9. Angeard N., Gargiulo M., Jacquette A., et al. Cognitive profile in childhood myotonic dystrophy type 1: is there a global impairment?. Neuromuscul Disord 2007, 17:451-458.
10. Antonini G., Soscia F., Giubilei F., et al. Health-related quality of life in myotonic dystrophy type 1 and its relationship with cognitive and emotional functioning. J Rehabil Med 2006, 38:181-185.
11. Arakawa K., Tomi H., Tobimatsu S., et al. Middle latency auditory-evoked potentials in myotonic dystrophy: relation to the size of the CTG trinucleotide repeat and intelligent quotient. J Neurol Sci 2003, 207:31-36.
12. Arsenault M.E., Prevost C., Lescault A., et al. Clinical characteristics of myotonic dystrophy type 1 patients with small CTG expansions. Neurology 2006, 66:1248-1250.
13. Ashizawa T., Conneally P.M. Repeats may not be everything in anticipation. Neurology 1999, 53:1164-1165.
14. Ashizawa T., Epstein H.F. Ethnic distribution of myotonic dystrophy gene. Lancet 1991, 338:642-643.
15. Ashizawa T., Harper P.S. Mytonic dystrophies. Emery and Rimoin's Principles and Practice of Medical Genetics 2006, 3047-3071. Bermedica Production, Columbia. 5th edn. D.L. Rimoin, M. Connor, R.E. Pyeritz, B.R. Korf (Eds.).
16. Ashizawa T., Dubel J.R., Harati Y. Somatic instability of CTG repeat in myotonic dystrophy. Neurology 1993, 43:2674-2678.
17. Ashizawa T., Anvret M., Baiget M., et al. Characteristics of intergenerational contractions of the CTG repeat in myotonic dystrophy. Am J Hum Genet 1994, 54:414-423.
18. Aslanidis C., Jansen G., Amemiya C., et al. Cloning of the essential myotonic dystrophy region and mapping of the putative defect. Nature 1992, 355:548-551.
19. Bachinski L.L., Udd B., Meola G., et al. Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect. Am J Hum Genet 2003, 73:835-848.
20. Bachinski L.L., Czernuszewicz T., Ramagli L.S., et al. Pre-mutation allele pool in myotonic dystrophy type 2 (DM2). Neurology 2009, 72:484-485.
21. Baig K.M., Discepola M. Recurrent capsular opacification after Nd:YAG laser treatment in myotonic dystrophy. Can J Ophthalmol 2007, 42:489-490.
22. Banerjee D., McClintock J., Silver M.M., et al. Monocyte IgG-Fc receptors in myotonic dystrophy. Clin Exp Immunol 1982, 50:572-578.
23. Bassez G., Lazarus A., Desguerre I., et al. Severe cardiac arrhythmias in young patients with myotonic dystrophy type 1. Neurology 2004, 63:1939-1941.
24. Basu P., Majumder P.P., Roychoudhury S., et al. Haplotype analysis of genomic polymorphisms in and around the myotonic dystrophy locus in diverse populations of India. Hum Genet 2001, 108:310-317.
25. Batten F.E., Gibb H.P. Myotonia atrophica. Brain 1909, 32:187-205.
26. Begin P., Mathieu J., Almirall J., et al. Relationship between chronic hypercapnia and inspiratory-muscle weakness in myotonic dystrophy. Am J Respir Crit Care Med 1997, 156:133-139.
27. Bell M.A., Johnson A.K., Testa S.M. Ribozyme-catalyzed excision of targeted sequences from within RNAs. Biochemistry 2002, 41:15327-15333.
28. Bellini M., Biagi S., Stasi C., et al. Gastrointestinal manifestations in myotonic muscular dystrophy. World J Gastroenterol 2006, 12:1821-1828.
29. Bhagavati S., Ghatpande A., Leung B. Identification of two nuclear proteins which bind to RNA CUG repeats: significance for myotonic dystrophy. Biochem Biophys Res Commun 1996, 228:55-62.
30. Bhakta D., Lowe M.R., Groh W.J. Prevalence of structural cardiac abnormalities in patients with myotonic dystrophy type I. Am Heart J 2004, 147:224-227.
31. Blumgart C.H., Hughes D.G., Redfern N. Obstetric anaesthesia in dystrophia myotonica. Anaesthesia 1990, 45:26-29.
32. Bollinger K.E., Kattouf V., Arthur B., et al. Hypermetropia and esotropia in myotonic dystrophy. J AAPOS 2008, 12:69-71.
33. Bonifazi E., Vallo L., Giardina E., et al. A long PCR-based molecular protocol for detecting normal and expanded ZNF9 alleles in myotonic dystrophy type 2. Diagn Mol Pathol 2004, 13:164-166.
34. Bonifazi E., Gullotta F., Vallo L., et al. Use of RNA fluorescence in situ hybridization in the prenatal molecular diagnosis of myotonic dystrophy type I. Clin Chem 2006, 52:319-322.
35. Botta A., Vallo L., Rinaldi F., et al. Gene expression analysis in myotonic dystrophy: indications for a common molecular pathogenic pathway in DM1 and DM2. Gene Expr 2007, 13:339-351.
36. Boucher C.A., King S.K., Carey N., et al. A novel homeodomain-encoding gene is associated with a large CpG island interrupted by the myotonic dystrophy unstable (CTG)n repeat. Hum Mol Genet 1995, 4:1919-1925.
37. Boyle R. Antenatal and preoperative genetic and clinical assessment in myotonic dystrophy. Anaesth Intensive Care 1999, 27:301-306.
38. Brisson D., Tremblay M., Prevost C., et al. Sibship stability of genotype and phenotype in myotonic dystrophy. Clin Genet 2002, 62:220-225.
39. Brook J.D., McCurrach M.E., Harley H.G., et al. Molecular basis of myotonic dystrophy: expansion of a trinucleotide (CTG) repeat at the 3' end of a transcript encoding a protein kinase family member. Cell 1992, 68:799-808.
40. Brunner H.G., Hamel B.C., Rieu P., et al. Intestinal pseudo-obstruction in myotonic dystrophy. J Med Genet 1992, 29:791-793.
41. Brunner H.G., Nillesen W., van Oost B.A., et al. Presymptomatic diagnosis of myotonic dystrophy. J Med Genet 1992, 29:780-784.
42. Brunner H.G., Bruggenwirth H.T., Nillesen W., et al. Influence of sex of the transmitting parent as well as of parental allele size on the CTG expansion in myotonic dystrophy (DM). Am J Hum Genet 1993, 53:1016-1023.
43. Brunner H.G., Jansen G., Nillesen W., et al. Brief report: reverse mutation in myotonic dystrophy. N Engl J Med 1993, 328:476-480.
44. Buj-Bello A., Furling D., Tronchere H., et al. Muscle-specific alternative splicing of myotubularin-related 1 gene is impaired in DM1 muscle cells. Hum Mol Genet 2002, 11:2297-2307.
45. Bushby K., Muntoni F., Bourke J.P. 107th ENMC international workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy. 7th-9th June 2002, Naarden, The Netherlands. Neuromuscul Disord 2003, 13:166-172.
46. Buxton J., Shelbourne P., Davies J., et al. Detection of an unstable fragment of DNA specific to individuals with myotonic dystrophy. Nature 1992, 355:47-548.
47. Callahan J.L., Andrews K.J., Zakian V.A., et al. Mutations in yeast replication proteins that increase CAG/CTG expansions also increase repeat fragility. Mol Cell Biol 2003, 23:7849-7860.
48. Campbell C., Sherlock R., Jacob P., et al. Congenital myotonic dystrophy: assisted ventilation duration and outcome. Pediatrics 2004, 113:811-816.
49. Cardani R., Mancinelli E., Rotondo G., et al. Muscleblind-like protein 1 nuclear sequestration is a molecular pathology marker of DM1 and DM2. Eur J Histochem 2006, 50:177-182.
50. Carey N., Johnson K., Nokelainen P., et al. Meiotic drive at the myotonic dystrophy locus?. Nat Genet 1994, 6:117-118.
51. Casella M., Dello Russo A., Pace M., et al. Heart rate turbulence as a noninvasive risk predictor of ventricular tachyarrhythmias in myotonic dystrophy type 1. J Cardiovasc Electrophysiol 2006, 17:871-876.
52. Chakraborty R., Stivers D.N., Deka R., et al. Segregation distortion of the CTG repeats at the myotonic dystrophy locus. Am J Hum Genet 1996, 59:109-118.
53. Charlet B.N., Savkur R.S., Singh G., et al. Loss of the muscle-specific chloride channel in type 1 myotonic dystrophy due to misregulated alternative splicing. Mol Cell 2002, 10:45-53.
54. Chen W., Liang Y., Deng W., et al. The zinc-finger protein CNBP is required for forebrain formation in the mouse. Development 2003, 130:1367-1379.
55. Cho D.H., Tapscott S.J. Myotonic dystrophy: emerging mechanisms for DM1 and DM2. Biochim Biophys Acta 2007, 1772:195-204.
56. Cho D.H., Thienes C.P., Mahoney S.E., et al. Antisense transcription and heterochromatin at the DM1 CTG repeats are constrained by CTCF. Mol Cell 2005, 20:483-489.
57. Chuang C.C., Lin H.C. Pilomatrixoma of the head and neck. J Chin Med Assoc 2004, 67:633-636.
58. Ciafaloni E., Mignot E., Sansone V., et al. The hypocretin neurotransmission system in myotonic dystrophy type 1. Neurology 2008, 70:226-230.
59. Clarke N.R., Kelion A.D., Nixon J., et al. Does cytosine-thymine-guanine (CTG) expansion size predict cardiac events and electrocardiographic progression in myotonic dystrophy?. Heart 2001, 86:411-416.
60. Cleary J.D., Pearson C.E. Replication fork dynamics and dynamic mutations: the fork-shift model of repeat instability. Trends Genet 2005, 21:272-280.
61. Cobo A.M., Poza J.J., Blanco A., et al. Frequency of myotonic dystrophy gene carriers in cataract patients. J Med Genet 1996, 33:221-223.
62. Costantini M., Zaninotto G., Anselmino M., et al. Esophageal motor function in patients with myotonic dystrophy. Dig Dis Sci 1996, 41:2032-2038.
63. Cros D., Harnden P., Pouget J., et al. Peripheral neuropathy in myotonic dystrophy: a nerve biopsy study. Ann Neurol 1988, 23:470-476.
64. Curschmann H. Über familiare atropische myotonica. Dtsch Z Nervenheilkd 1912, 45:161-202.
65. Dada T.O. Dystrophia myotonica in a Nigerian family. East Afr Med J 1973, 50:213-228.
66. Damian M.S., Gerlach A., Schmidt F., et al. Modafinil for excessive daytime sleepiness in myotonic dystrophy. Neurology 2001, 56:794-796.
67. Dansithong W., Paul S., Comai L., et al. MBNL1 is the primary determinant of focus formation and aberrant insulin receptor splicing in DM1. J Biol Chem 2005, 280:5773-5780.
68. Davis B.M., McCurrach M.E., Taneja K.L., et al. Expansion of a CUG trinucleotide repeat in the 3' untranslated region of myotonic dystrophy protein kinase transcripts results in nuclear retention of transcripts. Proc Natl Acad Sci U S A 1997, 94:7388-7393.
69. Day J.W., Ranum L.P. RNA pathogenesis of the myotonic dystrophies. Neuromuscul Disord 2005, 15:5-16.
70. Day J.W., Roelofs R., Leroy B., et al. Clinical and genetic characteristics of a five-generation family with a novel form of myotonic dystrophy (DM2). Neuromuscul Disord 1999, 9:19-27.
71. Day J.W., Ricker K., Jacobsen J.F., et al. Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum. Neurology 2003, 60:657-664.
72. Dean N.L., Loredo-Osti J.C., Fujiwara T.M., et al. Transmission ratio distortion in the myotonic dystrophy locus in human preimplantation embryos. Eur J Hum Genet 2006, 14:299-306.
73. De Die-Smulders C. Long-term Clinical and Genetic Studies in Myotonic Dystrophy 2000, University of Maastricht, Maastricht.
74. de Die-Smulders C.E., Howeler C.J., Mirandolle J.F., et al. Anticipation resulting in elimination of the myotonic dystrophy gene: a follow up study of one extended family. J Med Genet 1994, 31:595-601.
75. Delaporte C. Personality patterns in patients with myotonic dystrophy. Arch Neurol 1998, 55:635-640.
76. Dello Russo A., Pelargonio G., Parisi Q., et al. Widespread electroanatomic alterations of right cardiac chambers in patients with myotonic dystrophy type 1. J Cardiovasc Electrophysiol 2006, 17:34-40.
77. De Temmerman N., Sermon K., Seneca S., et al. Intergenerational instability of the expanded CTG repeat in the DMPK gene: studies in human gametes and preimplantation embryos. Am J Hum Genet 2004, 75:325-329.
78. Di Costanzo A., Santoro L., de Cristofaro M., et al. Familial aggregation of white matter lesions in myotonic dystrophy type 1. Neuromuscul Disord 2008, 18:299-305.
79. Di Leo R., Rodolico C., De Gregorio C., et al. Cardiovascular autonomic control in myotonic dystrophy type 1: a correlative study with clinical and genetic data. Neuromuscul Disord 2004, 14:36-141.
80. Duboc D., Eymard B., Damian M.S. Cardiac management of myotonic dystrophy. Myotonic Dystrophy: Present Management 2004, 85-93. Future Therapy. Oxford University Press, New York. P.S. Harper, B.M.G. Van Engelen, B. Eymard (Eds.).
81. Dubowitz V., Sewry C.A. Muscle Biopsy: A Practical Approach 2006, Saunders, London. 3rd edn.
82. Echenne B., Rideau A., Roubertie A., et al. Myotonic dystrophy type I in childhood. Long-term evolution in patients surviving the neonatal period. Eur J Paediatr Neurol 2008, 12:210-223.
83. Ekstrom A.B., Hakenas-Plate L., Samuelsson L., et al. Autism spectrum conditons in myotonic dystrophy type 1: a study on 57 individuals with congenital and childhood forms. Am J Med Genet B Neuropsychiatr Genet 2008, 147B:918-926.
84. Engvall M., Sjogreen L., Kjellberg H., et al. Oral health in children and adolescents with myotonic dystrophy. Eur J Oral Sci 2007, 115:192-197.
85. Eriksson M., Ansved T., Edstrom L., et al. Simultaneous analysis of expression of the three myotonic dystrophy locus genes in adult skeletal muscle samples: the CTG expansion correlates inversely with DMPK and 59 expression levels, but not DMAHP levels. Hum Mol Genet 1999, 8:1053-1060.
86. Fardaei M., Larkin K., Brook J.D., et al. In vivo co-localisation of MBNL protein with DMPK expanded-repeat transcripts. Nucleic Acids Res 2001, 29:2766-2771.
87. Fardaei M., Rogers M.T., Thorpe H.M., et al. Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells. Hum Mol Genet 2002, 11:805-814.
88. Filippova G.N., Thienes C.P., Penn B.H., et al. CTCF-binding sites flank CTG/CAG repeats and form a methylation-sensitive insulator at the DM1 locus. Nat Genet 2001, 28:335-343.
89. Foiry L., Dong L., Savouret C., et al. Msh3 is a limiting factor in the formation of intergenerational CTG expansions in DM1 transgenic mice. Hum Genet 2006, 119:520-526.
90. Fokstuen S., Myring J., Evans C., et al. Presymptomatic testing in myotonic dystrophy: genetic counselling approaches. J Med Genet 2001, 38:846-850.
91. Forsberg H., Olofsson B.O., Eriksson A., et al. Cardiac involvement in congenital myotonic dystrophy. Br Heart J 1990, 63:119-121.
92. Fortune M.T., Vassilopoulos C., Coolbaugh M.I., et al. Dramatic, expansion-biased, age-dependent, tissue-specific somatic mosaicism in a transgenic mouse model of triplet repeat instability. Hum Mol Genet 2000, 9:439-445.
93. Friedenberg W.R., Marx J.J., Hansotia P., et al. Granulocyte dysfunction and myotonic dystrophy. J Neurol Sci 1986, 73:1-10.
94. Frisch R., Singleton K.R., Moses P.A., et al. Effect of triplet repeat expansion on chromatin structure and expression of DMPK and neighboring genes, SIX5 and DMWD, in myotonic dystrophy. Mol Genet Metab 2001, 74:281-291.
95. Fu Y.H., Pizzuti A., Fenwick R.G., et al. An unstable triplet repeat in a gene related to myotonic muscular dystrophy. Science 1992, 255:1256-1258.
96. Fu Y.H., Friedman D.L., Richards S., et al. Decreased expression of myotonin-protein kinase messenger RNA and protein in adult form of myotonic dystrophy. Science 1993, 260:235-238.
97. Fukuda H., Horiguchi J., Ono C., et al. Diffusion tensor imaging of cerebral white matter in patients with myotonic dystrophy. Acta Radiol 2005, 46:104-109.
98. Furling D., Lemieux D., Taneja K., et al. Decreased levels of myotonic dystrophy protein kinase (DMPK) and delayed differentiation in human myotonic dystrophy myoblasts. Neuromuscul Disord 2001, 11:728-735.
99. Furling D., Doucet G., Langlois M.A., et al. Viral vector producing antisense RNA restores myotonic dystrophy myoblast functions. Gene Ther 2003, 10:795-802.
100. Gagnon C., Mathieu J., Noreau L. Life habits in myotonic dystrophy type 1. J Rehabil Med 2007, 39:560-566.
101. Gagnon C., Noreau L., Moxley R.T., et al. Towards an integrative approach to the management of myotonic dystrophy type 1. J Neurol Neurosurg Psychiatry 2007, 78:800-806.
102. Garcia de Andoin N., Echeverria J., Cobo A.M., et al. A neonatal form of Steinert's myotonic dystrophy in twins after in vitro fertilization. Fertil Steril 2005, 84:756.
103. Garrott H.M., Walland M.J., O'Day J. Recurrent posterior capsular opacification and capsulorhexis contracture after cataract surgery in myotonic dystrophy. Clin Experiment Ophthalmol 2004, 32:653-655.
104. Gaul C., Schmidt T., Windisch G., et al. Subtle cognitive dysfunction in adult onset myotonic dystrophy type 1 (DM1) and type 2 (DM2). Neurology 2006, 67:350-352.
105. Geifman-Holtzman O., Fay K. Prenatal diagnosis of congenital myotonic dystrophy and counseling of the pregnant mother: case report and literature review. Am J Med Genet 1998, 78:250-253.
106. Gennarelli M., Dallapiccola B., Baiget M., et al. Meiotic drive at the myotonic dystrophy locus. J Med Genet 1994, 31:980.
107. Gennarelli M., Novelli G., Andreasi Bassi F., et al. Prediction of myotonic dystrophy clinical severity based on the number of intragenic [CTG]n trinucleotide repeats. Am J Med Genet 1996, 65:342-347.
108. George A., Schneider-Gold C., Zier S., et al. Musculoskeletal pain in patients with myotonic dystrophy type 2. Arch Neurol 2004, 61:1938-1942.
109. Giordano M., Comoli A.M., De Angelis M.S., et al. Reassessment of the specificity of lens opacities in myotonic dystrophy. Ophthalmic Res 1996, 28:224-229.
110. Giorgio A., Dotti M.T., Battaglini M., et al. Cortical damage in brains of patients with adult-form of myotonic dystrophy type 1 and no or minimal MRI abnormalities. J Neurol 2006, 253:1471-1477.
111. Goldman A., Krause A., Ramsay M., et al. Founder effect and prevalence of myotonic dystrophy in South Africans: molecular studies. Am J Hum Genet 1996, 59:445-452.
112. Gomes-Pereira M., Monckton D.G. Chemically induced increases and decreases in the rate of expansion of a CAG*CTG triplet repeat. Nucleic Acids Res 2004, 32:2865-2872.
113. Gomes-Pereira M., Fortune M.T., Monckton D.G., et al. Mouse tissue culture models of unstable triplet repeats: in vitro selection for larger alleles, mutational expansion bias and tissue specificity, but no association with cell division rates. Hum Mol Genet 2001, 10:845-854.
114. Gomes-Pereira M., Foiry L., Gourdon G. Transgenic mouse models of unstable trinucleotide repeats. Genetic Instabilities and Neurological Diseases 2006, 563-683. Elsevier, San Diego. 2nd edn. R.D. Wells, T. Ashizawa (Eds.).
115. Gomes-Pereira M., Foiry L., Nicole A., et al. CTG trinucleotide repeat " big jumps": large expansions, small mice. PLoS Genet 2007, 3:e52.
116. Goossens E., Steyaert J., De Die-Smulders C., et al. Emotional and behavioral profile and child psychiatric diagnosis in the childhood type of myotonic dystrophy. Genet Couns 2000, 11:317-327.
117. Gourdon G., Radvanyi F., Lia A.S., et al. Moderate intergenerational and somatic instability of a 55-CTG repeat in transgenic mice. Nat Genet 1997, 15:190-192.
118. Greenfield J.G. Notes on a family of " myotonia atrophica" and early cataract, with a report of an additional case of " myotonia atrophica." Rev Neurol Psychiatry 1911, 9:169-181.
119. Griggs R.C., Pandya S., Florence J.M., et al. Randomized controlled trial of testosterone in myotonic dystrophy. Neurology 1989, 39:219-222.
120. Groenen P.J., Wansink D.G., Coerwinkel M., et al. Constitutive and regulated modes of splicing produce six major myotonic dystrophy protein kinase (DMPK) isoforms with distinct properties. Hum Mol Genet 2000, 9:605-616.
121. Groh W.J., Lowe M.R., Simmons Z., et al. Familial clustering of muscular and cardiac involvement in myotonic dystrophy type 1. Muscle Nerve 2005, 31:719-724.
122. Grove D.I., O'Callaghan S.J., Burston T.O., et al. Immunological function in dystrophia myotonica. Br Med J 1973, 3:81-83.
123. Guimaraes A.S., Carlsson G.E., Marie S.K. Bite force and handgrip force in patients with molecular diagnosis of myotonic dystrophy. J Oral Rehabil 2007, 34:195-200.
124. Hamshere M.G., Newman E.E., Alwazzan M., et al. Transcriptional abnormality in myotonic dystrophy affects DMPK but not neighboring genes. Proc Natl Acad Sci U S A 1997, 94:7394-7399.
125. Harley H.G., Brook J.D., Rundle S.A., et al. Expansion of an unstable DNA region and phenotypic variation in myotonic dystrophy. Nature 1992, 355:545-546.
126. Harper P.S. Congenital myotonic dystrophy in Britain. I. Clinical aspects. Arch Dis Child 1975, 50:505-513.
127. Harper P.S. Myotonic Dystrophy 1989, WB Saunders, Philadelphia.
128. Harper P.S. Myotonic Dystrophy 2001, Saunders, London. 3rd edn.
129. Harper P.S., Johnson K.J. Myotonic dystrophy. The Metabolic & Molecular Bases of Inherited Diseases 2001, 5525-5550. McGraw-Hill Medical Publishing Division, New York. 8th edn. C.R. Scriver, A.L. Beaudet, W.S. Sly (Eds.).
130. Harper P.S., van Engelen B., Eymard B., et al. Myotonic Dystrophy: Present Management, Future Therapy 2004, Oxford University Press, Oxford.
131. Hashem V.I., Pytlos M.J., Klysik E.A., et al. Chemotherapeutic deletion of CTG repeats in lymphoblast cells from DM1 patients. Nucleic Acids Res 2004, 32:6334-6346.
132. Hilton-Jones D., Damian M., Meola G. Somnolence and its management. Myotonic Dystrophy: Present Management, Future Therapy 2004, 135-152. Oxford University Press, New York. P.S. Harper, B. van Engelen, B. Eymard (Eds.).
133. Horowitz M., Maddox A., Maddern G.J., et al. Gastric and esophageal emptying in dystrophia myotonica. Effect of metoclopramide. Gastroenterology 1987, 92:570-577.
134. Ho T.H., Charlet B.N., Poulos M.G., et al. Muscleblind proteins regulate alternative splicing. EMBO J 2004, 23:3103-3112.
135. Ho T.H., Bundman D., Armstrong D.L., et al. Transgenic mice expressing CUG-BP1 reproduce splicing mis-regulation observed in myotonic dystrophy. Hum Mol Genet 2005, 14:1539-1547.
136. Ho T.H., Savkur R.S., Poulos M.G., et al. Colocalization of muscleblind with RNA foci is separable from mis-regulation of alternative splicing in myotonic dystrophy. J Cell Sci 2005, 118:2923-2933.
137. Howeler C.J., Busch H.F., Geraedts J.P., et al. Anticipation in myotonic dystrophy: fact or fiction?. Brain 1989, 112:779-797.
138. Huntington's Disease Collaborative Research Group A novel gene containing a trinucleotide repeat that is expanded and unstable on Huntington's disease chromosomes. Cell 1993, 72:971-983.
139. Ichikawa K., Kageyama Y., Fujioka A. [Sweating deficiency in myotonic dystrophy.]. Rinsho Shinkeigaku 1989, 29:707-712.
140. Imbert G., Kretz C., Johnson K., et al. Origin of the expansion mutation in myotonic dystrophy. Nat Genet 1993, 4:72-76.
141. International Myotonic Dystrophy Consortium New nomenclature and DNA testing guidelines for myotonic dystrophy type 1 (DM1). Neurology 2000, 54:1218-1221.
142. Jansen G., Willems P., Coerwinkel M., et al. Gonosomal mosaicism in myotonic dystrophy patients: involvement of mitotic events in (CTG)n repeat variation and selection against extreme expansion in sperm. Am J Hum Genet 1994, 54:575-585.
143. Jansen G., Bachner D., Coerwinkel M., et al. Structural organization and developmental expression pattern of the mouse WD-repeat gene DMR-N9 immediately upstream of the myotonic dystrophy locus. Hum Mol Genet 1995, 4:843-852.
144. Jansen G., Groenen P.J., Bachner D., et al. Abnormal myotonic dystrophy protein kinase levels produce only mild myopathy in mice. Nat Genet 1996, 13:316-324.
145. Jensen M.P., Hoffman A.J., Stoelb B.L., et al. Chronic pain in persons with myotonic dystrophy and facioscapulohumeral dystrophy. Arch Phys Med Rehabil 2008, 89:320-328.
146. Jiang H., Mankodi A., Swanson M.S., et al. Myotonic dystrophy type 1 is associated with nuclear foci of mutant RNA, sequestration of muscleblind proteins and deregulated alternative splicing in neurons. Hum Mol Genet 2004, 13:3079-3088.
147. Johansson A., Carlstrom K., Ahren B., et al. Abnormal cytokine and adrenocortical hormone regulation in myotonic dystrophy. J Clin Endocrinol Metab 2000, 85:3169-3176.
148. Johansson A., Andrew R., Forsberg H., et al. Glucocorticoid metabolism and adrenocortical reactivity to ACTH in myotonic dystrophy. J Clin Endocrinol Metab 2001, 86:4276-4283.
149. Johansson A., Ahren B., Forsberg H., et al. Testosterone and diurnal rhythmicity of leptin, TNF-alpha and TNF-II receptor in insulin-resistant myotonic dystrophy patients. Int J Obes Relat Metab Disord 2002, 26:1386-1392.
150. Johansson A., Olsson T., Cederquist K., et al. Abnormal release of incretins and cortisol after oral glucose in subjects with insulin-resistant myotonic dystrophy. Eur J Endocrinol 2002, 146:397-405.
151. Kakourou G., Dhanjal S., Daphnis D., et al. Preimplantation genetic diagnosis for myotonic dystrophy type 1: detection of crossover between the gene and the linked marker APOC2. Prenat Diagn 2007, 27:111-116.
152. Kakourou G., Dhanjal S., Mamas T., et al. Preimplantation genetic diagnosis for myotonic dystrophy type 1 in the UK. Neuromuscul Disord 2008, 18:131-136.
153. Kalkman J.S., Schillings M.L., Zwarts M.J., et al. Influence of relatives on fatigue experienced by patients with facioscapulohumeral dystrophy, myotonic dystrophy and HMSN-I. Eur Neurol 2006, 56:24-30.
154. Kalkman J.S., Schillings M.L., Zwarts M.J. Psychiatric disorders appear equally in patients with myotonic dystrophy, facioscapulohumeral dystrophy, and hereditary motor and sensory neuropathy type I. Acta Neurol Scand 2007, 115:265-270.
155. Kanadia R.N., Johnstone K.A., Mankodi A., et al. A muscleblind knockout model for myotonic dystrophy. Science 2003, 302:1978-1980.
156. Khajavi M., Tari A.M., Patel N.B., et al. " Mitotic drive" of expanded CTG repeats in myotonic dystrophy type 1 (DM1). Hum Mol Genet 2001, 10:855-863.
157. Kidd A., Turnpenny P., Kelly K., et al. Ascertainment of myotonic dystrophy through cataract by selective screening. J Med Genet 1995, 32:519-523.
158. Kierkegaard M., Tollback A. Reliability and feasibility of the six minute walk test in subjects with myotonic dystrophy. Neuromuscul Disord 2007, 17:943-949.
159. Kilic T., Vural A., Ural D., et al. Cardiac resynchronization therapy in a case of myotonic dystrophy (Steinert's disease) and dilated cardiomyopathy. Pacing Clin Electrophysiol 2007, 30:916-920.
160. Kim D.H., Langlois M.A., Lee K.B., et al. HnRNP H inhibits nuclear export of mRNA containing expanded CUG repeats and a distal branch point sequence. Nucleic Acids Res 2005, 33:3866-3874.
161. Kinoshita M., Takahashi R., Hasegawa T., et al. (CTG)n expansions in various tissues from a myotonic dystrophy patient. Muscle Nerve 1996, 19:240-242.
162. Kirby R.J., Hamilton G.M., Finnegan D.J., et al. Drosophila homolog of the myotonic dystrophy-associated gene, SIX5, is required for muscle and gonad development. Curr Biol 2001, 11:1044-1049.
163. Klesert T.R., Cho D.H., Clark J.I., et al. Mice deficient in Six5 develop cataracts: implications for myotonic dystrophy. Nat Genet 2000, 25:105-109.
164. Koch M.C., Grimm T., Harley H.G., et al. Genetic risks for children of women with myotonic dystrophy. Am J Hum Genet 1991, 48:1084-1091.
165. Korade-Mirnics Z., Tarleton J., Servidei S., et al. Myotonic dystrophy: tissue-specific effect of somatic CTG expansions on allele-specific DMAHP/SIX5 expression. Hum Mol Genet 1999, 8:1017-1023.
166. Kornblum C., Reul J., Kress W. Cranial magnetic resonance imaging in genetically proven myotonic dystrophy type 1 and 2. J Neurol 2004, 251:710-714.
167. Kornblum C., Lutterbey G., Bogdanow M., et al. Distinct neuromuscular phenotypes in myotonic dystrophy types 1 and 2: a whole body highfield MRI study. J Neurol 2006, 253:753-761.
168. Kovtun I.V., Liu Y., Bjoras M., et al. OGG1 initiates age-dependent CAG trinucleotide expansion in somatic cells. Nature 2007, 447:447-452.
169. Krahe R., Ashizawa T., Abbruzzese C., et al. Effect of myotonic dystrophy trinucleotide repeat expansion on DMPK transcription and processing. Genomics 1995, 28:1-14.
170. Krahe R., Eckhart M., Ogunniyi A.O., et al. De novo myotonic dystrophy mutation in a Nigerian kindred. Am J Hum Genet 1995, 56:1067-1074.
171. Krishnan A.V., Kiernan M.C. Axonal function and activity-dependent excitability changes in myotonic dystrophy. Muscle Nerve 2006, 33:627-636.
172. Kroksmark A.K., Ekstrom A.B., Bjorck E., et al. Myotonic dystrophy: muscle involvement in relation to disease type and size of expanded CTG-repeat sequence. Dev Med Child Neurol 2005, 47:478-485.
173. Kuo H.C., Hsiao K.M., Chen C.J., et al. Brain magnetic resonance image changes in a family with congenital and classic myotonic dystrophy. Brain Dev 2005, 27:291-296.
174. Kuo H.C., Hsieh Y.C., Wang H.M. Correlation among subcortical white matter lesions, intelligence and CTG repeat expansion in classic myotonic dystrophy type 1. Acta Neurol Scand 2008, 117:101-107.
175. Kuyumcu-Martinez N.M., Wang G.S., Cooper T.A. Increased steady-state levels of CUGBP1 in myotonic dystrophy 1 are due to PKC-mediated hyperphosphorylation. Mol Cell 2007, 28:68-78.
176. Laberge L., Gagnon C., Jean S., et al. Fatigue and daytime sleepiness rating scales in myotonic dystrophy: a study of reliability. J Neurol Neurosurg Psychiatry 2005, 76:1403-1405.
177. Laberge L., Veillette S., Mathieu J., et al. The correlation of CTG repeat length with material and social deprivation in myotonic dystrophy. Clin Genet 2007, 71:59-66.
178. Lahue R.S., Slater D.L. DNA repair and trinucleotide repeat instability. Front Biosci 2003, 8:s653-s665.
179. Lam L.T., Pham Y.C., Nguyen T.M., et al. Characterization of a monoclonal antibody panel shows that the myotonic dystrophy protein kinase, DMPK, is expressed almost exclusively in muscle and heart. Hum Mol Genet 2000, 9:2167-2173.
180. Langlois M.A., Lee N.S., Rossi J.J., et al. Hammerhead ribozyme-mediated destruction of nuclear foci in myotonic dystrophy myoblasts. Mol Ther 2003, 7:670-680.
181. Langlois M.A., Boniface C., Wang G., et al. Cytoplasmic and nuclear retained DMPK mRNAs are targets for RNA interference in myotonic dystrophy cells. J Biol Chem 2005, 280:16949-16954.
182. Laugel V., Cossee M., Matis J., et al. Diagnostic approach to neonatal hypotonia: retrospective study on 144 neonates. Eur J Pediatr 2008, 167:517-523.
183. Lazarus A., Varin J., Ounnoughene Z., et al. Relationships among electrophysiological findings and clinical status, heart function, and extent of DNA mutation in myotonic dystrophy. Circulation 1999, 99:1041-1046.
184. Lazarus A., Varin J., Babuty D., et al. Long-term follow-up of arrhythmias in patients with myotonic dystrophy treated by pacing: a multicenter diagnostic pacemaker study. J Am Coll Cardiol 2002, 40:1645-1652.
185. Lazarus A., Varin J., Jauvert G., et al. Relationship between cardiac arrhythmias and sleep apnoea in permanently paced patients with type I myotonic dystrophy. Neuromuscul Disord 2007, 17:392-399.
186. Le Ber I., Martinez M., Campion D., et al. A non-DM1, non-DM2 multisystem myotonic disorder with frontotemporal dementia: phenotype and suggestive mapping of the DM3 locus to chromosome 15q21-24. Brain 2004, 127:1979-1992.
187. Lecointe-Besancon I., Leroy F., Devroede G., et al. A comparative study of esophageal and anorectal motility in myotonic dystrophy. Dig Dis Sci 1999, 44:1090-1099.
188. Lia A.S., Seznec H., Hofmann-Radvanyi H., et al. Somatic instability of the CTG repeat in mice transgenic for the myotonic dystrophy region is age dependent but not correlated to the relative intertissue transcription levels and proliferative capacities. Hum Mol Genet 1998, 7:1285-1291.
189. Lindeman E., Spaans F., Reulen J., et al. Progressive resistance training in neuromuscular patients. Effects on force and surface EMG. J Electromyogr Kinesiol 1999, 9:379-384.
190. Liquori C.L., Ricker K., Moseley M.L., et al. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9. Science 2001, 293:864-867.
191. Liquori C.L., Ikeda Y., Weatherspoon M., et al. Myotonic dystrophy type 2: human founder haplotype and evolutionary conservation of the repeat tract. Am J Hum Genet 2003, 73:849-862.
192. Liu Y., Zhang H., Veeraraghavan J., et al. Saccharomyces cerevisiae flap endonuclease 1 uses flap equilibration to maintain triplet repeat stability. Mol Cell Biol 2004, 24:4049-4064.
193. Logigian E.L., Blood C.L., Dilek N., et al. Quantitative analysis of the "warm-up" phenomenon in myotonic dystrophy type 1. Muscle Nerve 2005, 32:35-42.
194. Logigian E.L., Ciafaloni E., Quinn L.C., et al. Severity, type, and distribution of myotonic discharges are different in type 1 and type 2 myotonic dystrophy. Muscle Nerve 2007, 35:479-485.
195. Logullo F., Censori B., Danni M., et al. Peripheral neuropathy in myotonic dystrophy: electrophysiological and clinical features. Electromyogr Clin Neurophysiol 1992, 32:515-520.
196. Lucchiari S., Pagliarani S., Corti S., et al. Colocalization of ribonuclear inclusions with muscle blind like-proteins in a family with myotonic dystrophy type 2 associated with a short CCTG expansion. J Neurol Sci 2008, 275:159-163.
197. McCallum R.W., Brown R.L. Diabetic and nondiabetic gastroparesis. Curr Treat Options Gastroenterol 1998, 1:1-7.
198. MacDonald J.R., Hill J.D., Tarnopolsky M.A. Modafinil reduces excessive somnolence and enhances mood in patients with myotonic dystrophy. Neurology 2002, 59:1876-1880.
199. Magee A.C., Hughes A.E. Segregation distortion in myotonic dystrophy. J Med Genet 1998, 35:1045-1046.
200. Mahadevan M., Tsilfidis C., Sabourin L., et al. Myotonic dystrophy mutation: an unstable CTG repeat in the 3' untranslated region of the gene. Science 1992, 255:1253-1255.
201. Mahadevan M.S., Yadava R.S., Yu Q., et al. Reversible model of RNA toxicity and cardiac conduction defects in myotonic dystrophy. Nat Genet 2006, 38:1066-1070.
202. Mankodi A., Logigian E., Callahan L., et al. Myotonic dystrophy in transgenic mice expressing an expanded CUG repeat. Science 2000, 289:1769-1773.
203. Mankodi A., Urbinati C.R., Yuan Q.P., et al. Muscleblind localizes to nuclear foci of aberrant RNA in myotonic dystrophy types 1 and 2. Hum Mol Genet 2001, 10:2165-2170.
204. Mankodi A., Takahashi M.P., Jiang H., et al. Expanded CUG repeats trigger aberrant splicing of ClC-1 chloride channel pre-mRNA and hyperexcitability of skeletal muscle in myotonic dystrophy. Mol Cell 2002, 10:35-44.
205. Mankodi A., Teng-Umnuay P., Krym M., et al. Ribonuclear inclusions in skeletal muscle in myotonic dystrophy types 1 and 2. Ann Neurol 2003, 54:760-768.
206. Martinez-Rodriguez J.E., Lin L., Iranzo A., et al. Decreased hypocretin-1 (orexin-A) levels in the cerebrospinal fluid of patients with myotonic dystrophy and excessive daytime sleepiness. Sleep 2003, 26:287-290.
207. Martorell L., Illa I., Rosell J., et al. Homozygous myotonic dystrophy: clinical and molecular studies of three unrelated cases. J Med Genet 1996, 33:783-785.
208. Martorell L., Monckton D.G., Gamez J., et al. Progression of somatic CTG repeat length heterogeneity in the blood cells of myotonic dystrophy patients. Hum Mol Genet 1998, 7:307-312.
209. Martorell L., Monckton D.G., Sanchez A., et al. Frequency and stability of the myotonic dystrophy type 1 premutation. Neurology 2001, 56:328-335.
210. Martorell L., Gamez J., Cayuela M.L., et al. Germline mutational dynamics in myotonic dystrophy type 1 males: allele length and age effects. Neurology 2004, 62:269-274.
211. Martorell L., Cobo A.M., Baiget M., et al. Prenatal diagnosis in myotonic dystrophy type 1. Thirteen years of experience: implications for reproductive counselling in DM1 families. Prenat Diagn 2007, 27:68-72.
212. Mastroyiannopoulos N.P., Feldman M.L., Uney J.B., et al. Woodchuck post-transcriptional element induces nuclear export of myotonic dystrophy 3' untranslated region transcripts. EMBO Rep 2005, 6:458-463.
213. Mathieu J., Allard P., Gobeil G., et al. Anesthetic and surgical complications in 219 cases of myotonic dystrophy. Neurology 1997, 49:1646-1650.
214. Medica I., Teran N., Volk M., et al. Patients with primary cataract as a genetic pool of DMPK protomutation. J Hum Genet 2007, 52:123-128.
215. Mege J.L., Pouget J., Capo C., et al. Myotonic dystrophy: defective oxidative burst of polymorphonuclear leukocytes. J Leukoc Biol 1988, 44:180-186.
216. Meola G., Sansone V. Cerebral involvement in myotonic dystrophies. Muscle Nerve 2007, 36:294-306.
217. Meola G., Sansone V., Perani D., et al. Executive dysfunction and avoidant personality trait in myotonic dystrophy type 1 (DM-1) and in proximal myotonic myopathy (PROMM/DM-2). Neuromuscul Disord 2003, 13:813-821.
218. Merlini L., Sabatelli P., Columbaro M., et al. Hyper-CK-emia as the sole manifestation of myotonic dystrophy type 2. Muscle Nerve 2005, 31:764-767.
219. Michalowski S., Miller J.W., Urbinati C.R., et al. Visualization of double-stranded RNAs from the myotonic dystrophy protein kinase gene and interactions with CUG-binding protein. Nucleic Acids Res 1999, 27:3534-3542.
220. Miller J.W., Urbinati C.R., Teng-Umnuay P., et al. Recruitment of human muscleblind proteins to (CUG)(n) expansions associated with myotonic dystrophy. EMBO J 2000, 19:4439-4448.
221. Mistry D.J., Moorman J.R., Reddy S., et al. Skeletal muscle Na currents in mice heterozygous for Six5 deficiency. Physiol Genomics 2001, 6:153-158.
222. Modolell I., Mearin F., Baudet J.S., et al. Pharyngo-esophageal motility disturbances in patients with myotonic dystrophy. Scand J Gastroenterol 1999, 34:878-882.
223. Modoni A., Silvestri G., Pomponi M.G. Characterization of the pattern of cognitive impairment in myotonic dystrophy type 1. Arch Neurol 2004, 61:1943-1947.
224. Monckton D.G., Ashizawa T. Molecular aspects of myotonic dystrophy: our current understanding. Myotonic Dystrophy: Present Management, Future Therapy 2004, 14-36. Oxford University Press, Oxford. P.S. Harper, B. van Engelen, B. Eymard (Eds.).
225. Monckton D.G., Wong L.J., Ashizawa T., et al. Somatic mosaicism, germline expansions, germline reversions and intergenerational reductions in myotonic dystrophy males: small pool PCR analyses. Hum Mol Genet 1995, 4:1-8.
226. Monckton D.G., Coolbaugh M.I., Ashizawa K.T., et al. Hypermutable myotonic dystrophy CTG repeats in transgenic mice. Nat Genet 1997, 15:193-196.
227. Mondelli M., Rossi A., Malandrini A., et al. Axonal motor and sensory neuropathy in myotonic dystrophy. Acta Neurol Scand 1993, 88:141-148.
228. Morgenlander J.C., Nohria V., Saba Z. EKG abnormalities in pediatric patients with myotonic dystrophy. Pediatr Neurol 1993, 9:124-126.
229. Morimoto Y., Mii M., Hirata T., et al. Target-controlled infusion of propofol for a patient with myotonic dystrophy. J Anesth 2005, 19:336-338.
230. Morrone A., Pegoraro E., Angelini C., et al. RNA metabolism in myotonic dystrophy: patient muscle shows decreased insulin receptor RNA and protein consistent with abnormal insulin resistance. J Clin Invest 1997, 99:1691-1698.
231. Mounsey J.P., John J.E., Helmke S.M., et al. Phospholemman is a substrate for myotonic dystrophy protein kinase. J Biol Chem 2000, 275:23362-23367.
232. Mounsey J.P., Mistry D.J., Ai C.W., et al. Skeletal muscle sodium channel gating in mice deficient in myotonic dystrophy protein kinase. Hum Mol Genet 2000, 9:2313-2320.
233. Moxley R.T., Griggs R.C., Goldblatt D., et al. Decreased insulin sensitivity of forearm muscle in myotonic dystrophy. J Clin Invest 1978, 62:857-867.
234. Moxley R.T., Livingston J.N., Lockwood D.H., et al. Abnormal regulation of monocyte insulin-binding affinity after glucose ingestion in patients with myotonic dystrophy. Proc Natl Acad Sci U S A 1981, 78:2567-2571.
235. Moxley R.T., Pandya S., Thornton C.A., et al. Therapeutic trials and future advances. Myotonic Dystrophy: Present Management 2004, 219-239. Future Therapy. Oxford University Press, New York. P.S. Harper, B. van Engelen, B. Eymard (Eds.).
236. Moxley R.T., Logigian E.L., Martens W.B., et al. Computerized hand grip myometry reliably measures myotonia and muscle strength in myotonic dystrophy (DM1). Muscle Nerve 2007, 36:320-328.
237. Muranyi A., Zhang R., Liu F., et al. Myotonic dystrophy protein kinase phosphorylates the myosin phosphatase targeting subunit and inhibits myosin phosphatase activity. FEBS Lett 2001, 493:80-84.
238. Muraoka H., Negoro N., Terasaki F., et al. Re-entry circuit in ventricular tachycardia due to focal fatty-fibrosis in a patient with myotonic dystrophy. Intern Med 2005, 44:129-135.
239. Myring J., Meredith A.L., Harley H.G., et al. Specific molecular prenatal diagnosis for the CTG mutation in myotonic dystrophy. J Med Genet 1992, 29:785-788.
240. Nagamitsu S., Ashizawa T. Myotonic dystrophies. Adv Neurol 2002, 88:293-314.
241. Neville C.E., Mahadevan M.S., Barcelo J.M., et al. High resolution genetic analysis suggests one ancestral predisposing haplotype for the origin of the myotonic dystrophy mutation. Hum Mol Genet 1994, 3:45-51.
242. Nishi M., Itoh H., Tsubokawa T., et al. Effective doses of vecuronium in a patient with myotonic dystrophy. Anaesthesia 2004, 59:1216-1218.
243. Nowak T.V., Anuras S., Brown B.P., et al. Small intestinal motility in myotonic dystrophy patients. Gastroenterology 1984, 86:808-813.
244. Nugent A.M., Smith I.E., Shneerson J.M. Domiciliary-assisted ventilation in patients with myotonic dystrophy. Chest 2002, 121:459-464.
245. O'Cochlain D.F., Perez-Terzic C., Reyes S., et al. Transgenic overexpression of human DMPK accumulates into hypertrophic cardiomyopathy, myotonic myopathy and hypotension traits of myotonic dystrophy. Hum Mol Genet 2004, 13:2505-2518.
246. O'Hoy K.L., Tsilfidis C., Mahadevan M.S., et al. Reduction in size of the myotonic dystrophy trinucleotide repeat mutation during transmission. Science 1993, 259:809-812.
247. Orengo J.P., Chambon P., Metzger D., et al. Expanded CTG repeats within the DMPK 3' UTR causes severe skeletal muscle wasting in an inducible mouse model for myotonic dystrophy. Proc Natl Acad Sci U S A 2008, 105:2646-2651.
248. Orngreen M.C., Olsen D.B., Vissing J. Aerobic training in patients with myotonic dystrophy type 1. Ann Neurol 2005, 57:754-757.
249. Ota M., Sato N., Ohya Y., et al. Relationship between diffusion tensor imaging and brain morphology in patients with myotonic dystrophy. Neurosci Lett 2006, 407:234-239.
250. Oyamada R., Hayashi M., Katoh Y., et al. Neurofibrillary tangles and deposition of oxidative products in the brain in cases of myotonic dystrophy. Neuropathology 2006, 26:107-114.
251. Parisi M., Galderisi M., Sidiropulos M., et al. Early detection of biventricular involvement in myotonic dystrophy by tissue Doppler. Int J Cardiol 2007, 118:227-232.
252. Pearson C.E. Slipping while sleeping? Trinucleotide repeat expansions in germ cells. Trends Mol Med 2003, 9:490-495.
253. Pearson C.E., Sinden R.R. Alternative structures in duplex DNA formed within the trinucleotide repeats of the myotonic dystrophy and fragile X loci. Biochemistry 1996, 35:5041-5053.
254. Pearson C.E., Nichol Edamura K., Cleary J.D. Repeat instability: mechanisms of dynamic mutations. Nat Rev Genet 2005, 6:729-742.
255. Pelargonio G., Dello Russo A., Sanna T., et al. Myotonic dystrophy and the heart. Heart 2002, 88:665-670.
256. Penrose L.S. The problem of anticipation in pedigrees of dystrophia myotonica. Ann Eugen 1948, 14:125-132.
257. Perseghin G., Caumo A., Arcelloni C., et al. Contribution of abnormal insulin secretion and insulin resistance to the pathogenesis of type 2 diabetes in myotonic dystrophy. Diabetes Care 2003, 26:2112-2118.
258. Personius K.E., Nautiyal J., Reddy S. Myotonia and muscle contractile properties in mice with SIX5 deficiency. Muscle Nerve 2005, 31:503-505.
259. Philips A.V., Timchenko L.T., Cooper T.A. Disruption of splicing regulated by a CUG-binding protein in myotonic dystrophy. Science 1998, 280:737-741.
260. Phillips M.F., Harper P.S. Cardiac disease in myotonic dystrophy. Cardiovasc Res 1997, 33:13-22.
261. Phillips M.F., Rogers M.T., Barnetson R., et al. PROMM: the expanding phenotype. A family with proximal myopathy, myotonia and deafness. Neuromuscul Disord 1998, 8:439-446.
262. Phylactou L.A. Repair of myotonic dystrophy protein kinase (DMPK) transcripts by trans-splicing ribozymes. Methods Mol Biol 2004, 252:373-383.
263. Prevost C., Veillette S., Perron M., et al. Psychosocial impact of predictive testing for myotonic dystrophy type 1. Am J Med Genet A 2004, 126:68-77.
264. Quera Salva M.A., Blumen M., Jacquette A., et al. Sleep disorders in childhood-onset myotonic dystrophy type 1. Neuromuscul Disord 2006, 16:564-570.
265. Ranum L.P., Rasmussen P.F., Benzow K.A., et al. Genetic mapping of a second myotonic dystrophy locus. Nat Genet 1998, 19:196-198.
266. Reddy S., Smith D.B., Rich M.M., et al. Mice lacking the myotonic dystrophy protein kinase develop a late onset progressive myopathy. Nat Genet 1996, 13:325-335.
267. Reddy S., Mistry D.J., Wang Q.C., et al. Effects of age and gene dose on skeletal muscle sodium channel gating in mice deficient in myotonic dystrophy protein kinase. Muscle Nerve 2002, 25:850-857.
268. Redman J.B., Fenwick R.G., Fu Y.H., et al. Relationship between parental trinucleotide GCT repeat length and severity of myotonic dystrophy in offspring. JAMA 1993, 269:1960-1965.
269. Ricker K., Koch M.C., Lehmann-Horn F., et al. Proximal myotonic myopathy. Clinical features of a multisystem disorder similar to myotonic dystrophy. Arch Neurol 1995, 52:25-31.
270. Ricker K., Grimm T., Koch M.C., et al. Linkage of proximal myotonic myopathy to chromosome 3q. Neurology 1999, 52:170-171.
271. Roberts R., Timchenko N.A., Miller J.W., et al. Altered phosphorylation and intracellular distribution of a (CUG)n triplet repeat RNA-binding protein in patients with myotonic dystrophy and in myotonin protein kinase knockout mice. Proc Natl Acad Sci U S A 1997, 94:13221-13226.
272. Rogers M.T., Clyburn P.A. Anaesthesia and myotonic dystrophy. Myotonic Dystrophy: Present Management 2004, 94-103. Future Therapy. Oxford University Press, New York. P.S. Harper, B. Van Engelen, B. Eymard (Eds.).
273. Ronnblom A., Forsberg H., Danielsson A. Gastrointestinal symptoms in myotonic dystrophy. Scand J Gastroenterol 1996, 31:654-657.
274. Ronnblom A., Andersson S., Danielsson A. Mechanisms of diarrhoea in myotonic dystrophy. Eur J Gastroenterol Hepatol 1998, 10:607-610.
275. Ronnblom A., Danielsson A., el-Salhy M. Intestinal endocrine cells in myotonic dystrophy: an immunocytochemical and computed image analytical study. J Intern Med 1999, 245:91-97.
276. Ronnblom A., Hellstrom P.M., Holst J.J., et al. Gastric myoelectrical activity and gut hormone secretion in myotonic dystrophy. Eur J Gastroenterol Hepatol 2001, 13:825-831.
277. Ronnblom A., Andersson S., Hellstrom P.M., et al. Gastric emptying in myotonic dystrophy. Eur J Clin Invest 2002, 32:570-574.
278. Rudnik-Schoneborn S., Schneider-Gold C., Raabe U., et al. Outcome and effect of pregnancy in myotonic dystrophy type 2. Neurology 2006, 66:579-580.
279. Saito T., Amakusa Y., Kimura T., et al. Myotonic dystrophy type 2 in Japan: ancestral origin distinct from Caucasian families. Neurogenetics 2008, 9:61-63.
280. Salehi L.B., Bonifazi E., Stasio E.D., et al. Risk prediction for clinical phenotype in myotonic dystrophy type 1: data from 2,650 patients. Genet Test 2007, 11:84-90.
281. Sallinen R., Vihola A., Bachinski L.L., et al. New methods for molecular diagnosis and demonstration of the (CCTG)n mutation in myotonic dystrophy type 2 (DM2). Neuromuscul Disord 2004, 14:274-283.
282. Sansone V., Gandossini S., Cotelli M., et al. Cognitive impairment in adult myotonic dystrophies: a longitudinal study. Neurol Sci 2007, 28:9-15.
283. Sarkar P.S., Appukuttan B., Han J., et al. Heterozygous loss of Six5 in mice is sufficient to cause ocular cataracts. Nat Genet 2000, 25:110-114.
284. Sarkar P.S., Paul S., Han J., et al. Six5 is required for spermatogenic cell survival and spermiogenesis. Hum Mol Genet 2004, 13:1421-1431.
285. Satoyoshi E. A syndrome of progressive muscle spasm, alopecia, and diarrhea. Neurology 1978, 28:458-471.
286. Savkur R.S., Philips A.V., Cooper T.A. Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy. Nat Genet 2001, 29:40-47.
287. Savkur R.S., Philips A.V., Cooper T.A., et al. Insulin receptor splicing alteration in myotonic dystrophy type 2. Am J Hum Genet 2004, 74:1309-1313.
288. Savouret C., Brisson E., Essers J., et al. CTG repeat instability and size variation timing in DNA repair-deficient mice. EMBO J 2003, 22:2264-2273.
289. Savouret C., Garcia-Cordier C., Megret J., et al. MSH2-dependent germinal CTG repeat expansions are produced continuously in spermatogonia from DM1 transgenic mice. Mol Cell Biol 2004, 24:629-637.
290. Schneider C., Ziegler A., Ricker K., et al. Proximal myotonic myopathy: evidence for anticipation in families with linkage to chromosome 3q. Neurology 2000, 55:383-388.
291. Schoser B., Ashizawa T. How much expansion to be diseased?: towards repeat size and myotonic dystrophy type 2. Neurology 2009, 72:484-485.
292. Schoser B.G., Kress W., Walter M.C., et al. Homozygosity for CCTG mutation in myotonic dystrophy type 2. Brain 2004, 127:1868-1877.
293. Schoser B.G., Ricker K., Schneider-Gold C., et al. Sudden cardiac death in myotonic dystrophy type 2. Neurology 2004, 63:2402-2404.
294. Schoser B.G., Schneider-Gold C., Kress W., et al. Muscle pathology in 57 patients with myotonic dystrophy type 2. Muscle Nerve 2004, 29:275-281.
295. Seay A.R., Ziter F.A., Hill H.R. Defective neutrophil function in myotonic dystrophy. J Neurol Sci 1978, 35:25-30.
296. Sergeant N., Sablonniere B., Schraen-Maschke S., et al. Dysregulation of human brain microtubule-associated tau mRNA maturation in myotonic dystrophy type 1. Hum Mol Genet 2001, 10:2143-2155.
297. Sermon K., Seneca S., De Rycke M., et al. PGD in the lab for triplet repeat diseases - myotonic dystrophy, Huntington's disease and fragile-X syndrome. Mol Cell Endocrinol 2001, 183:S77-S85.
298. Seznec H., Lia-Baldini A.S., Duros C., et al. Transgenic mice carrying large human genomic sequences with expanded CTG repeat mimic closely the DM CTG repeat intergenerational and somatic instability. Hum Mol Genet 2000, 9:1185-1194.
299. Shaunak S., Orrell R., Henderson L., et al. Saccades and smooth pursuit in myotonic dystrophy. J Neurol 1999, 246:600-606.
300. Sherman S.L., Jacobs P.A., Morton N.E., et al. Further segregation analysis of the fragile X syndrome with special reference to transmitting males. Hum Genet 1985, 69:289-299.
301. Siegel C.I., Hendrix T.R., Harvey J.C. The swallowing disorder in myotonia dystrophica. Gastroenterology 1966, 50:541-550.
302. Simmons Z., Thornton C.A., Seltzer W.K., et al. Relative stability of a minimal CTG repeat expansion in a large kindred with myotonic dystrophy. Neurology 1998, 50:1501-1504.
303. Sjogreen L., Engvall M., Ekstrom A.B., et al. Orofacial dysfunction in children and adolescents with myotonic dystrophy. Dev Med Child Neurol 2007, 49:18-22.
304. Sovari A.A., Bodine C.K., Farokhi F. Cardiovascular manifestations of myotonic dystrophy-1. Cardiol Rev 2007, 15:191-194.
305. Steinbach P., Glaser D., Vogel W., et al. The DMPK gene of severely affected myotonic dystrophy patients is hypermethylated proximal to the largely expanded CTG repeat. Am J Hum Genet 1998, 62:278-285.
306. Steinert H.H.W. Myopathologische Beiträge. I. Über das klinische und anatomische Bilde des Muskelschwunds des Myotoniker. Dtsch Z Nervenheilkd 1909, 37:58-104.
307. Storbeck C.J., Drmanic S., Daniel K., et al. Inhibition of myogenesis in transgenic mice expressing the human DMPK 3'-UTR. Hum Mol Genet 2004, 13:589-600.
308. Sugino M., Ohsawa N., Ito T., et al. A pilot study of dehydroepiandrosterone sulfate in myotonic dystrophy. Neurology 1998, 51:586-589.
309. Sumi M., Kusumoto T., Tagawa M., et al. Two infantile cases of congenital myotonic dystrophy with cholelithiasis/cholestasis. Pediatr Int 2005, 47:586-588.
310. Sunwoo I.N. Clinical application of muscle biopsy. J Korean Neurol Assoc 2001, 19:67-87.
311. Suominen T., Auvinen S., Hannonen P., et al. Myotonic dystrophy type 2 (DM2) may be misdiagnosed as fibromyalgia. Neuromuscul Disord 2007, 17:858-859.
312. Takhar A.S., Thaper A., Byrne A., et al. Laparoscopic cholecystectomy in a patient with myotonic dystrophy. J R Soc Med 2004, 97:284-285.
313. Talbot K., Stradling J., Crosby J., et al. Reduction in excess daytime sleepiness by modafinil in patients with myotonic dystrophy. Neuromuscul Disord 2003, 13:357-364.
314. Taneja K.L., McCurrach M., Schalling M., et al. Foci of trinucleotide repeat transcripts in nuclei of myotonic dystrophy cells and tissues. J Cell Biol 1995, 128:995-1002.
315. Tapscott S.J. Deconstructing myotonic dystrophy. Science 2000, 289:1701-1702.
316. Thornton C.A., Griggs R.C., Moxley R.T. Myotonic dystrophy with no trinucleotide repeat expansion. Ann Neurol 1994, 35:269-272.
317. Thornton C.A., Johnson K., Moxley R.T. Myotonic dystrophy patients have larger CTG expansions in skeletal muscle than in leukocytes. Ann Neurol 1994, 35:104-107.
318. Thornton C.A., Wymer J.P., Simmons Z., et al. Expansion of the myotonic dystrophy CTG repeat reduces expression of the flanking DMAHP gene. Nat Genet 1997, 16:407-409.
319. Tieleman A.A., van Vliet J., Jansen J.B., et al. Gastrointestinal involvement is frequent in myotonic dystrophy type 2. Neuromuscul Disord 2008, 18:646-649.
320. Timchenko L., Nastainczyk W., Schneider T., et al. Full-length myotonin protein kinase (72 kDa) displays serine kinase activity. Proc Natl Acad Sci U S A 1995, 92:5366-5370.
321. Timchenko L.T., Miller J.W., Timchenko N.A., et al. Identification of a (CUG)n triplet repeat RNA-binding protein and its expression in myotonic dystrophy. Nucleic Acids Res 1996, 24:4407-4414.
322. Timchenko L.T., Timchenko N.A., Caskey C.T., et al. Novel proteins with binding specificity for DNA CTG repeats and RNA CUG repeats: implications for myotonic dystrophy. Hum Mol Genet 1996, 5:115-121.
323. Timchenko N.A., Cai Z.J., Welm A.L., et al. RNA CUG repeats sequester CUGBP1 and alter protein levels and activity of CUGBP1. J Biol Chem 2001, 276:7820-7826.
324. Timchenko N.A., Iakova P., Cai Z.J., et al. Molecular basis for impaired muscle differentiation in myotonic dystrophy. Mol Cell Biol 2001, 21:6927-6938.
325. Timchenko N.A., Patel R., Iakova P., et al. Overexpression of CUG triplet repeat-binding protein, CUGBP1, in mice inhibits myogenesis. J Biol Chem 2004, 279:13129-13139.
326. Tiscornia G., Mahadevan M.S. Myotonic dystrophy: the role of the CUG triplet repeats in splicing of a novel DMPK exon and altered cytoplasmic DMPK mRNA isoform ratios. Mol Cell 2000, 5:959-967.
327. Tishkoff S.A., Goldman A., Calafell F., et al. A global haplotype analysis of the myotonic dystrophy locus: implications for the evolution of modern humans and for the origin of myotonic dystrophy mutations. Am J Hum Genet 1998, 62:1389-1402.
328. Tollback A., Eriksson S., Wredenberg A., et al. Effects of high resistance training in patients with myotonic dystrophy. Scand J Rehabil Med 1999, 31:9-16.
329. Traboulsi E.I., Chung D., Koors J.M. Polychromasia capsulare (multicolored capsule): report of three families. Trans Am Ophthalmol Soc 2005, 103:93-97.
330. Udd B., Meola G., Krahe R., et al. Report of the 115th ENMC workshop: DM2/PROMM and other myotonic dystrophies. 3rd Workshop, 14-16 February 2003, Naarden, The Netherlands. Neuromuscul Disord 2003, 13:589-596.
331. Udd B., Meola G., Krahe R., et al. 140th ENMC International Workshop: Myotonic Dystrophy DM2/PROMM and other myotonic dystrophies with guidelines on management. Neuromuscul Disord 2006, 16:403-413.
332. Ueda H., Shimokawa M., Yamamoto M., et al. Decreased expression of myotonic dystrophy protein kinase and disorganization of sarcoplasmic reticulum in skeletal muscle of myotonic dystrophy. J Neurol Sci 1999, 162:38-50.
333. van den Broek W.J., Nelen M.R., Wansink D.G., et al. Somatic expansion behaviour of the (CTG)n repeat in myotonic dystrophy knock-in mice is differentially affected by Msh3 and Msh6 mismatch-repair proteins. Hum Mol Genet 2002, 11:191-198.
334. van den Broek W.J., Nelen M.R., van der Heijden G.W., et al. Fen1 does not control somatic hypermutability of the (CTG)(n)*(CAG)(n) repeat in a knock-in mouse model for DM1. FEBS Lett 2006, 580:5208-5214.
335. van den Broek W.J., Wansink D.G., Wieringa B. Somatic CTG CAG repeat instability in a mouse model for myotonic dystrophy type 1 is associated with changes in cell nuclearity and DNA ploidy. BMC Mol Biol 2007, 8:61.
336. van Engelen B.G.M., Brunner H.G. Gastrointestinal dysfunction in myotonic dystrophy. Myotonic Dystrophy: Present Management 2004, 113-125. Future Therapy. Oxford University Press, New York. P.S. Harper, B.M.G. van Engelen, B. Eymard (Eds.).
337. Vermersch P., Sergeant N., Ruchoux M.M., et al. Specific tau variants in the brains of patients with myotonic dystrophy. Neurology 1996, 47:711-717.
338. Versino M., Rossi B., Beltrami G., et al. Ocular motor myotonic phenomenon in myotonic dystrophy. J Neurol Neurosurg Psychiatry 2002, 72:236-240.
339. 1H magnetic resonance spectroscopic differences in myotonic dystrophy type 2 and type 1. Muscle Nerve 2006, 34:145-152.
340. Vignaux O., Lazarus A., Varin J., et al. Right ventricular MR abnormalities in myotonic dystrophy and relationship with intracardiac electrophysiologic test findings: initial results. Radiology 2002, 224:231-235.
341. Vihola A., Bassez G., Meola G., et al. Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM/DM2. Neurology 2003, 60:1854-1857.
342. Vinereanu D., Bajaj B.P., Fenton-May J., et al. Subclinical cardiac involvement in myotonic dystrophy manifesting as decreased myocardial Doppler velocities. Neuromuscul Disord 2004, 14:188-194.
343. Vlachopapadopoulou E., Zachwieja J.J., Gertner J.M., et al. Metabolic and clinical response to recombinant human insulin-like growth factor I in myotonic dystrophy - a clinical research center study. J Clin Endocrinol Metab 1995, 80:3715-3723.
344. Wakimoto H., Maguire C.T., Sherwood M.C., et al. Characterization of cardiac conduction system abnormalities in mice with targeted disruption of Six5 gene. J Interv Card Electrophysiol 2002, 7:127-135.
345. Wang J., Pegoraro E., Menegazzo E., et al. Myotonic dystrophy: evidence for a possible dominant-negative RNA mutation. Hum Mol Genet 1995, 4:599-606.
346. Wang Y.H., Amirhaeri S., Kang S., et al. Preferential nucleosome assembly at DNA triplet repeats from the myotonic dystrophy gene. Science 1994, 265:669-671.
347. Wansink D.G., van Herpen R.E., Coerwinkel-Driessen M.M., et al. Alternative splicing controls myotonic dystrophy protein kinase structure, enzymatic activity, and subcellular localization. Mol Cell Biol 2003, 23:5489-5501.
348. Warner J.P., Barron L.H., Goudie D., et al. A general method for the detection of large CAG repeat expansions by fluorescent PCR. J Med Genet 1996, 33:1022-1026.
349. Weiss K., Shapira Y., Glick B., et al. Congenital myopathies in Israeli families. J Child Neurol 2007, 22:732-736.
350. Wells R.D., Ashizawa T. Genetic Instabilities and Neurological Disorders 2006, Elsevier, Burlington. 2nd edn.
351. Wheeler T.M., Lueck J.D., Swanson M.S., et al. Correction of ClC-1 splicing eliminates chloride channelopathy and myotonia in mouse models of myotonic dystrophy. J Clin Invest 2007, 117:3952-3957.
352. Whittaker R.G., Ferenczi E., Hilton-Jones D. Myotonic dystrophy: practical issues relating to assessment of strength. J Neurol Neurosurg Psychiatry 2006, 77:1282-1283.
353. Winblad S., Lindberg C., Hansen S. Temperament and character in patients with classical myotonic dystrophy type 1 (DM-1). Neuromuscul Disord 2005, 15:287-292.
354. Winblad S., Hellstrom P., Lindberg C., et al. Facial emotion recognition in myotonic dystrophy type 1 correlates with CTG repeat expansion. J Neurol Neurosurg Psychiatry 2006, 77:219-223.
355. Winchester C.L., Ferrier R.K., Sermoni A., et al. Characterization of the expression of DMPK and SIX5 in the human eye and implications for pathogenesis in myotonic dystrophy. Hum Mol Genet 1999, 8:481-492.
356. Wintzen A.R., Lammers G.J., van Dijk J.G. Does modafinil enhance activity of patients with myotonic dystrophy? A double-blind placebo-controlled crossover study. J Neurol 2007, 254:26-28.
357. Wochner R.D., Drews G., Strober W., et al. Accelerated breakdown of immunoglobulin G (IgG) in myotonic dystrophy: a hereditary error of immunoglobulin catabolism. J Clin Invest 1966, 45:321-329.
358. Wong L.J., Ashizawa T., Monckton D.G., et al. Somatic heterogeneity of the CTG repeat in myotonic dystrophy is age and size dependent. Am J Hum Genet 1995, 56:114-122.
359. Yang J., Freudenreich C.H. Haploinsufficiency of yeast FEN1 causes instability of expanded CAG/CTG tracts in a length-dependent manner. Gene 2007, 393:110-115.
360. Zaki M., Boyd P.A., Impey L., et al. Congenital myotonic dystrophy: prenatal ultrasound findings and pregnancy outcome. Ultrasound Obstet Gynecol 2007, 29:284-288.
361. Zatz M., Cerqueira A., Vainzof M., et al. Segregation distortion of the CTG repeats at the myotonic dystrophy (DM) locus: new data from Brazilian DM families. J Med Genet 1997, 34:790-791.
362. Zeesman S., Carson N., Whelan D.T. Paternal transmission of the congenital form of myotonic dystrophy type 1: a new case and review of the literature. Am J Med Genet 2002, 107:222-226.
363. Zerylnick C., Torroni A., Sherman S.L., et al. Normal variation at the myotonic dystrophy locus in global human populations. Am J Hum Genet 1995, 56:123-130.
364. Zhang Y., Monckton D.G., Siciliano M.J., et al. Age and insertion site dependence of repeat number instability of a human DM1 transgene in individual mouse sperm. Hum Mol Genet 2002, 11:791-798.
365. Zunz E., Abeliovich D., Halpern G.J., et al. Myotonic dystrophy - no evidence for preferential transmission of the mutated allele: a prenatal analysis. Am J Med Genet A 2004, 127:50-53.